Hologic
Hologic Fiscal Q3 Revenues Beat Estimates on Rising Non-COVID Sales
The firm posted double-digit growth in non-COVID-19 molecular diagnostics revenues and continues working to bring its Mobidiag products to the US market.
Top Five Articles on 360Dx Last Week: Coverage of Cancer Tests Rescinded; FDA Clearances; and More
Last week, readers were most interested in a story about Medicare Administrative Contractor Novitas rescinding its coverage for several cancer genetic tests.
Abbott, Hologic, Becton Dickinson Secure FDA Clearances in May
The clearances granted in May by the US Food and Drug Administration include a laboratory instrument system, respiratory disease panels, and MRSA detection software.
Hologic Nabs FDA 510(k) Clearance for Respiratory Assay
The multiplex real-time RT-PCR test for SARS-CoV-2, influenza A and B, and RSV is designed for use on the firm's high-throughput Panther Fusion instrument.
Hologic Fiscal Q2 Revenues Drop 29 Percent With Fall in COVID-19 Assay Sales
The firm posted 20 percent organic growth excluding COVID-19-related income and is eyeing potential M&A deals that could "bulk up" its existing businesses.